🧵 5. Eli Lilly's stock surges 10% in premarket trading after strong Q2 results. Positive trial results for Alzheimer's drug and progress in obesity drug pipeline contribute to company's success.
You are viewing a single comment's thread from:
🧵 5. Eli Lilly's stock surges 10% in premarket trading after strong Q2 results. Positive trial results for Alzheimer's drug and progress in obesity drug pipeline contribute to company's success.